Lipophagy: a new player in CNS disorders

被引:31
|
作者
Haidar, Mansour [1 ]
Loix, Melanie [1 ]
Bogie, Jeroen F. J. [1 ]
Hendriks, Jerome J. A. [1 ]
机构
[1] Hasselt Univ, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium
来源
关键词
CHAPERONE-MEDIATED AUTOPHAGY; LYSOSOMAL ACID LIPASE; ALPHA-SYNUCLEIN; LIPID DROPLETS; LIPOLYSIS; MACROPHAGES; PROTEIN; MODEL; MACROAUTOPHAGY; ASSOCIATION;
D O I
10.1016/j.tem.2021.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipophagy is the process of selective degradation of lipid droplets (LDs) by autophagy. Several studies have highlighted the importance of lipophagy in regulating cellular lipid levels in various tissues and disease conditions. In recent years, disruption of autophagy and accumulation of LDs have been reported as pathological hallmarks in several neurodegenerative and neuroinflammatory diseases, raising the question whether lipophagy is a process that is important in the progression of these disorders. This supports the growing interest in lipid metabolism as a major player in neurodegeneration, and the emerging understanding of several neurological pathologies as not only proteinopathies but also lipidopathies. In this review we discuss the importance of lipophagy in the most common central nervous system diseases. We examine the latest evidence for the reported interplay between abnormalities in lipid accumulation and autophagy, and propose lipophagy as a potentially important mechanism in neurodegeneration.
引用
收藏
页码:941 / 951
页数:11
相关论文
共 50 条
  • [1] A new player in CNS myelination
    Spiegel, I
    Peles, E
    NEURON, 2006, 49 (06) : 777 - 778
  • [2] Emerging role of lipophagy in liver disorders
    Bismillah Nazeer
    Muhammad Babar Khawar
    Muhammad Usman Khalid
    Syeda Eisha Hamid
    Mussarat Rafiq
    Muddasir Hassan Abbasi
    Nadeem Sheikh
    Ahmad Ali
    Hooriya Fatima
    Sadia Ahmad
    Molecular and Cellular Biochemistry, 2024, 479 : 1 - 11
  • [3] Emerging role of lipophagy in liver disorders
    Nazeer, Bismillah
    Khawar, Muhammad Babar
    Khalid, Muhammad Usman
    Hamid, Syeda Eisha
    Rafiq, Mussarat
    Abbasi, Muddasir Hassan
    Sheikh, Nadeem
    Ali, Ahmad
    Fatima, Hooriya
    Ahmad, Sadia
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (01) : 1 - 11
  • [4] Lipophagy: Molecular Mechanisms and Implications in Metabolic Disorders
    Shin, Dong Wook
    MOLECULES AND CELLS, 2020, 43 (08) : 686 - 693
  • [5] Autophagy, lipophagy and lysosomal lipid storage disorders
    Ward, Carl
    Martinez-Lopez, Nuria
    Otten, Elsje G.
    Carroll, Bernadette
    Maetzel, Dorothea
    Singh, Rajat
    Sarkar, Sovan
    Korolchuk, Viktor I.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (04): : 269 - 284
  • [6] 5-Hydroxymethylcytosine: A new player in brain disorders?
    Cheng, Ying
    Bernstein, Alison
    Chen, Dahua
    Jin, Peng
    EXPERIMENTAL NEUROLOGY, 2015, 268 : 3 - 9
  • [7] Synaptic Function and Dysfunction: New Frontiers in CNS Disorders
    Aslan, Feyza Sule
    Akdag, Mahmut Berat
    Doganyigit, Zuleyha
    Okan, Asli
    Shaikh, Mohd. Farooq
    Akyuz, Enes
    JOURNAL OF NEUROSCIENCE RESEARCH, 2025, 103 (04)
  • [8] New GPCR targets and modulators to treat CNS disorders
    De Deurwaerdere, Philippe
    Ponimaskin, Evgeni
    Chagraoui, Abdeslam
    Di Giovanni, Giuseppe
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [9] Rethinking CNS disorders: time for new drug targets?
    Kalueff, Allan V.
    Stewart, Adam Michael
    Gottesman, Irving I.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (10) : 491 - 492
  • [10] Orexin Receptor Antagonists: A New Concept In CNS Disorders?
    Gatfield, John
    Brisbare-Roch, Catherine
    Jenck, Francois
    Boss, Christoph
    CHEMMEDCHEM, 2010, 5 (08) : 1197 - 1214